igf-1 lr3 legal IGF-1LR3 Unlocking the Power of IGF-1
Description
B.MarcelloM
Discussion We demonstrated that the pathogenicity of clinical C
The similarity in fatigue reports between active and placebo groups suggests that not all cases were causally related to AOD-9604
Mol Pharm 8, 21422150
